Healthcare Professionals
Visia AF VR
Implantable Cardioverter Defibrillators (ICDs)
Du har precis klickat på en länk som tar dig till en annan webbplats. Om du fortsätter kommer du att lämna denna webbplats och gå till en webbplats som drivs av någon annan.
Medtronic Sverige varken granskar eller kontrollerar innehållet på den andra webbplatsen och tar inget ansvar för eventuella affärstransaktioner som du utför där. Din användning av den andra webbplatsen är föremål för användarvillkoren och sekretesspolicyn på den webbplatsen.
Det är möjligt att vissa produkter på den andra platsen inte är godkända i Sverige.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Välkommen till vår information för hälso- och sjukvårdspersonal.
Här hittar du produktinformation och annan info framtagen för dig som arbetar inom vården.
Arbetar du inom ett vårdyrke?
Healthcare Professionals
Implantable Cardioverter Defibrillators (ICDs)
The only single chamber implantable cardioverter defibrillator (ICD) with a traditional lead, which enables physicians to continuously monitor, diagnose, and manage atrial fibrillation (AF) patients.
Schloss EJ, et al. How Common is New Onset Atrial Fibrillation in Single Chamber ICD Patients? Sub-analysis from the PainFree SST Study. Presented at AHA 2015 (Abstract 17946).
Wolff PA, Abbott RD, Kannel WB, et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. August 1991;22(8):983-988.
Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley Study. Am J Med. October 1, 2002;113(5):359-364.
Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm. February 2005;2(2):125-131.
Verma A, Champagne J, Sapp J, et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med. January 28, 2013;173(2):149-156.
Orlov MV, Ghali JK, Araghi-Niknam M, et al. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial. Pacing Clin Electrophysiol. March 2007;30(3):404-411.
Quirino G, Giammaria M, Corbucci G, et al. Diagnosis of paroxysmal atrial fibrillation in patients with implanted pacemakers: relationship to symptoms and other variables. Pacing Clin Electrophysiol. January 2009;32(1):91-98.
Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. January 1994;89(1):224-227.
Ziegler PD, Koehler JL, Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm. December 2006;3(12):1445-1452.
Years of Active In Vivo Data Reported by Manufacturer in Product Performance Report. Data as of November 2, 2015.
Auricchio A, Schloss EJ, Kurita T, et al. Low inappropriate shock rates in patients with single and dual/triple-chamber implantable cardioverter defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. Heart Rhythm. May 2015;12(5):926-936.
Flo, Daniel. Device Shape Analysis. January 2013. Medtronic data on file.
Limited lifetime warranty, some restrictions may apply. The limited lifetime warranty applies to the performance of the device and includes some reimbursement to patients of unreimbursed medical expenses. The warranty is limited to the provisions in the written Limited Warranty document that accompanies each product. Consult the written limited warranty document for details, a copy of which will be provided upon request.
Based on clinically proven AF detection,1 Visia AF has high AF burden and episode sensitivity.
Hindricks G, Pokushalov E, Urban L, et al. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial. Circ Arrythm Electrophysiol April 2010; 3(2):141-147.
Medtronic data on file. Visia AF MRI Detection Performance Validation Overview. E. Higgins.
Visia AF provides valuable information to aid decision making. Evaluate AF episodes and burden with programmable alerts to help manage AF patients.